Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/21/2007 | EP1856062A1 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine mediated diseases |
11/21/2007 | EP1856044A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
11/21/2007 | EP1856026A1 Purification process |
11/21/2007 | EP1855695A1 Solid pharmaceutical composition comprising telithromycin |
11/21/2007 | EP1855691A2 The use of thiophosphonoformic acid and nrtis to treat viral infections |
11/21/2007 | EP1855690A2 A tetracycline metal complex in a solid dosage form |
11/21/2007 | EP1855669A1 Liposomal compositions for parenteral delivery of agents |
11/21/2007 | EP1670448B1 Hcv inhibiting sulfonamides |
11/21/2007 | EP1585752B1 Polyene polyketides, processes for their production and their use as a pharmaceutical |
11/21/2007 | EP1578750B1 Cationic porphyrin derivatives as antibacterial agents |
11/21/2007 | EP1525223B1 Ox40 (=cd134) receptor agonists and therapeutic use |
11/21/2007 | EP1505975B1 Compositions and method for treating infection in cattle and swine |
11/21/2007 | EP1474135B1 Indole, azaindole and related heterocyclic pyrrolidine derivatives |
11/21/2007 | EP1423102B1 Plaster for the treatment of dysfunctions and disorders of nail growth |
11/21/2007 | EP1385498B1 Fatty acids as neutrophil survival and activation factors. |
11/21/2007 | EP1357917B9 Use of carbohydrates for eliminating intestinal infections in animals |
11/21/2007 | EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
11/21/2007 | EP1269196B1 Method of screening for inhibitors of osteopontin |
11/21/2007 | EP1200459B1 Compounds for treatment of infectious and immune system disorders and methods for their use |
11/21/2007 | EP0970087B1 A process for the preparation of a metal salt of clavulanic acid |
11/21/2007 | EP0904378B1 Hepatitis b monoclonal antibodies |
11/21/2007 | CN101076516A Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
11/21/2007 | CN101076346A Lactic acid bacteria and its application in preventing diarrhea |
11/21/2007 | CN101076336A Novel curcumin analogues and uses thereof |
11/21/2007 | CN101076325A Medicinal composition of edible carboxylic-acid and/or its acid salts and caffeine and non-drug addiction coffee |
11/21/2007 | CN101074267A Transduced peptide-humanized granular leukocyte macrophage colony stimulating factor fusion protein and its medicinal composition |
11/21/2007 | CN101074266A Transduced peptide-humanized granular leukocyte colony stimulating factor fusion protein and its medicinal composition |
11/21/2007 | CN101074260A Production of hygrophilous monospermous bacterium main-protective antigen univalent and multivalent vitelline antibody and use in aquatic animal |
11/21/2007 | CN101074253A Macrolide-dimer derivative, its production, and medicinal composition |
11/21/2007 | CN101074252A 11,20-cyclic carbonate-azithromycin 4-phenproester derivative, its production and medicinal composition |
11/21/2007 | CN101074251A Azithromycin 4-phenproester derivative, its production and medicinal composition |
11/21/2007 | CN101074249A Aminoglycoside antibiotics derivative |
11/21/2007 | CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound |
11/21/2007 | CN101074236A N,N-bi-substituted-methylpyrazole (4,5,e) (2,1,3)-thiadiazine-2,2,4-triketone derivative, its production and use |
11/21/2007 | CN101074228A Method for preparing medicine composition containing 1,3-oxathin cyclopentane nucleoside analogues |
11/21/2007 | CN101074220A Dehydroandrographolide succinate semialdehyde compound, its production and medicine |
11/21/2007 | CN101074210A Pharmaceutically active isoindoline derivatives |
11/21/2007 | CN101073660A Chinese-medicinal composition for treating chronic hepatitis B and its production |
11/21/2007 | CN101073640A Externally-applied medicine for treating moist wart |
11/21/2007 | CN101073629A Externally-applied health-care products for relieving itch and its production |
11/21/2007 | CN101073625A Medicinal composition with anti-infective and anti-inflammatory functions |
11/21/2007 | CN101073624A Chinese-medicinal preparation with stink-dispelling and itching-relieving functions for beriberi |
11/21/2007 | CN101073609A Fuming cirrus for treating hepatitis B, its production and use |
11/21/2007 | CN101073599A Total tanshinone and total phenolic acid extract in red-rooted salvia root and its production |
11/21/2007 | CN101073595A Glycyrrhiza total flavonoid and total saponin extract and its production |
11/21/2007 | CN101073589A Freeze-drying powder injection for treating calor febrilis and its production |
11/21/2007 | CN101073583A Use of red nocardial cell wall skeleton in preparation of medicine |
11/21/2007 | CN101073576A Aldoforwe ester self-emulsifying capsule preparation and its making method |
11/21/2007 | CN101073569A Medicine for preventing respiratory viruses and its use |
11/21/2007 | CN101073555A Injecting tanshinone II and its derivative concentrated solution and its production |
11/21/2007 | CN100350050C Pseudomycin production by pseudomonas syringae |
11/21/2007 | CN100350048C Recombinant bacillus Calmette-Guerin vaccine and its preparation method |
11/21/2007 | CN100349915C Amido glycoside of sea pearl oyster, prepartion method, and usage |
11/21/2007 | CN100349913C 2'-fluoronucleosides |
11/21/2007 | CN100349895C Pyrrolopyridazine derivatives |
11/21/2007 | CN100349888C Medicine compound |
11/21/2007 | CN100349632C Microprojection array having beneficial agent contg coating |
11/21/2007 | CN100349627C Medical devices containing rapamycin analogs |
11/21/2007 | CN100349580C Mould catching agent and medicinal/health caring use |
11/21/2007 | CN100349571C Transdermal therapeutic system containing testosterone and method for the production thereof |
11/21/2007 | CN100349562C Ophthalmic drug delivery device |
11/20/2007 | US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
11/20/2007 | US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics |
11/20/2007 | US7297784 Genetic enhancers comprising amino acid sequences derived from retrovirus envelope proteins coupled to core peptides, used as drugs having improve half life |
11/20/2007 | US7297763 Mixture of IGF-1 and N,N-bis(3-D-gluconamidopropyl)-deoxycholamine that binds specifically to IGF-1 and blocks binding of IGFBP-1 and IGFBP-3; used as a standard for identifying IGF-1 indirect agonists |
11/20/2007 | US7297687 Method of treating infectious diseases with polysaccharide derivatives |
11/20/2007 | US7297683 Crystalline forms of an antiviral benzimidazole compound |
11/20/2007 | US7297682 liquid crystal diphosphate polymorph; antibacterial and antiprotozoal agents |
11/20/2007 | US7297681 For use in therapy of growth metabolic disorders |
11/20/2007 | US7297533 Two types of foreign genes inserted in such a manner as to allow the expression into two different regions in the recombinant feline herpesvirus type 1 genome |
11/20/2007 | US7297523 Human elongase genes and uses thereof |
11/20/2007 | US7297509 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
11/20/2007 | US7297338 Genetic engineered mutant microorganisms ; synergistic mixture |
11/20/2007 | CA2423783C Inhibition of systemic infections in humans and vertebrates by dietary fibers |
11/20/2007 | CA2417843C Administration of an injectable antibiotic in the ear of an animal |
11/20/2007 | CA2316841C Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
11/20/2007 | CA2211389C Novel pharmaceutical combination |
11/20/2007 | CA2204745C Antiparasitic composition for the treatment and protection of pets |
11/20/2007 | CA2171743C Nucleotide analogs |
11/20/2007 | CA1341561C Manufacture and expression of large structural genes |
11/16/2007 | CA2588656A1 Antimicrobial hand wash formulations |
11/15/2007 | WO2007130783A2 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates |
11/15/2007 | WO2007130616A2 Polyamides for treating human papilloma virus |
11/15/2007 | WO2007130499A2 Antiviral agents |
11/15/2007 | WO2007129951A1 Virus susceptibility by plant nucleosomes |
11/15/2007 | WO2007129743A1 Anti-inflammatory composition |
11/15/2007 | WO2007129618A1 Inhibitor of neutrophil activation/migration factor and use thereof |
11/15/2007 | WO2007129290A1 Statins for the treatment of viral influenza infections |
11/15/2007 | WO2007129119A1 Pentacyclic indole derivatives as antiviral agents |
11/15/2007 | WO2007129083A1 Anti-viral pyrimidine nucleoside derivatives |
11/15/2007 | WO2007129020A1 Pyrimidine derivatives useful as dhfr inhibitors |
11/15/2007 | WO2007129019A1 Sulfonamide compounds useful as edg receptor modulators |
11/15/2007 | WO2007128914A1 Novel drugs for anti-herpes virus treatments |
11/15/2007 | WO2007128782A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes |
11/15/2007 | WO2007128555A1 Inhibition of gliotoxin |
11/15/2007 | WO2007128482A1 Use of a b-cell-depleting antibody for treatment of polyoma virus infections |
11/15/2007 | WO2007128191A1 Anti-hepatitis b virus inhibitorand use thereof |
11/15/2007 | WO2007128169A1 RECOMBINANT NEWCASTLE DISEASE LaSota LOW VIRULENT VACCINE STRAIN EXPRESSING AVIAN INFLUENZA VIRUS H5 SUBTYPE HA PROTEIN |
11/15/2007 | WO2007128136A1 A novel pilin glycoprotein from a group 4 pseudomonas aeruginosa strain |
11/15/2007 | WO2007128059A1 Bis-pyridinium compounds |